Likun Chen

10PUBLICATIONS
50CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanofabrication, growth and self assembly
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 04, 2026
Izalontamab Brengitecan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical EGFR Mutations: A Phase Ib Study.

Huaqiang Zhou, Hongyun Zhao, Xue Hou

|Dec 15, 2025
Magnetic resonance-guided split-course hypo-fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non-small cell lung cancer: A single arm, phase 2 study.

PengXin Zhang, DaQuan Wang, ShaoHan Yin

|Apr 12, 2024
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study.

Baishen Zhang, Yao Liu, Zhiting Chen

|Mar 25, 2024
Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer.

Baishen Zhang, Jing Chen, Hui Yu

|Apr 27, 2023
N6-Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung Cancer.

Haisheng Zhang, Jiawang Zhou, Jiexin Li

|Jan 12, 2023
Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity.

Xiaomin Zhang, Limin Cheng, Chengqi Gao

Pageof 2

Frequent Collaborators

2 joint publications

Hongsheng Wang

2 joint publications

Baishen Zhang

1 joint publications

Qiuxiang Ou

1 joint publications

Hua Bao